Bristol-Myers Squibb makes $12 million investment in Compugen, sets up research partnership

Credit: Proactive Investors- Published on October 11, 2018
US pharmaceutical giant Bristol-Myers Squibb (NYSE:BMY) has agreed to make a $12 million investment in Compugen Ltd (NASDAQ:CGEN), the Israeli drug developer, as part of a new partnership between the companies, which also involves shared cancer trials. The new trials will evaluate the safety and tolerability of Compugen’s...

Recent related videos from verified sources

Researchers Awarded $1 Million Prize At Magee-Womens Research Summit 00:41
Credit: KDKA CBS 2 Pittsburgh - Published on October 10, 2018 

U.S. Investment Rules To Get Tougher Soon 00:58
Credit: Wochit Business - Published on October 10, 2018 

Mega Millions Jackpot Soars To $548 Million 00:24
Credit: WJZ Baltimore - Published on October 10, 2018 

AM Buffalo on the Road - Part 2 Picking out the Perfect Pumpkin 02:30
Credit: Rumble - Published on October 8, 2018 

School Funding Goes Directly Before Florida Voters 00:55
Credit: Wochit News - Published on October 9, 2018 

Kickstarter Campaigns - Barley & Britches (Part 1) | FT Business 02:51
Credit: Financial Times - Published on October 8, 2018 

You might like